Roche stock is falling after report its Wegovy challenger is causing patients to vomit

?w=2048

Positive results in the early stages of Roche's weight-loss pill development had given investors hope it could quickly catch up with rivals Novo Nordisk and Eli Lilly.

https://fortune.com/europe/2024/09/12/roche-stock-falling-after-report-causing-patients-vomit/

Reply to this note

Please Login to reply.

Discussion

No replies yet.